C9orf72 and frontotemporal dementia: Interventional trials for FTD caused by the C9orf72 gene expansion (FTD-C9orf72) have also begun and include a novel antisense oligonucleotide trial (NCT04931862) and a monoclonal antibody trial (NCT03987295).